VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
+0.15%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$474M
AUM Growth
+$427M
Cap. Flow
+$429M
Cap. Flow %
90.37%
Top 10 Hldgs %
10.55%
Holding
454
New
296
Increased
64
Reduced
55
Closed
20

Top Buys

1
OXLC
Oxford Lane Capital
OXLC
$6.67M
2
BBDC icon
Barings BDC
BBDC
$6.25M
3
OXSQ icon
Oxford Square Capital
OXSQ
$5.46M
4
ECC
Eagle Point Credit Co
ECC
$5.43M
5
FSK icon
FS KKR Capital
FSK
$5.08M

Top Sells

1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$2.25M
2
ARRY
Array Biopharma Inc
ARRY
$999K
3
ACOR
Acorda Therapeutics, Inc.
ACOR
$644K
4
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
$603K
5
QURE icon
uniQure
QURE
$459K

Sector Composition

1 Financials 23.58%
2 Real Estate 14.99%
3 Energy 13.55%
4 Healthcare 12.23%
5 Materials 8.21%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AKBA icon
201
Akebia Therapeutics
AKBA
$787M
$315K 0.07%
65,063
+31,549
+94% +$153K
CYTK icon
202
Cytokinetics
CYTK
$6.32B
$315K 0.07%
27,962
-5,796
-17% -$65.3K
RETA
203
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$309K 0.07%
3,273
-1,123
-26% -$106K
SGMO icon
204
Sangamo Therapeutics
SGMO
$167M
$308K 0.06%
+28,643
New +$308K
TCDA
205
DELISTED
Tricida, Inc. Common Stock
TCDA
$306K 0.06%
7,762
-865
-10% -$34.1K
FATE icon
206
Fate Therapeutics
FATE
$115M
$304K 0.06%
14,965
-1,647
-10% -$33.5K
CBAY
207
DELISTED
Cymabay Therapeutics
CBAY
$304K 0.06%
42,473
+11,526
+37% +$82.5K
GRTS
208
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$302K 0.06%
+27,130
New +$302K
AGEN
209
Agenus
AGEN
$137M
$301K 0.06%
5,109
-367
-7% -$21.6K
AXSM icon
210
Axsome Therapeutics
AXSM
$6.24B
$301K 0.06%
+11,692
New +$301K
PHAS
211
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$301K 0.06%
+22,949
New +$301K
PRTA icon
212
Prothena Corp
PRTA
$456M
$300K 0.06%
28,379
+5,461
+24% +$57.7K
PTCT icon
213
PTC Therapeutics
PTCT
$4.56B
$300K 0.06%
6,660
-1,287
-16% -$58K
VYGR icon
214
Voyager Therapeutics
VYGR
$234M
$300K 0.06%
11,011
-14,640
-57% -$399K
IMMU
215
DELISTED
Immunomedics Inc
IMMU
$299K 0.06%
+21,587
New +$299K
BCRX icon
216
BioCryst Pharmaceuticals
BCRX
$1.74B
$298K 0.06%
78,684
+47,407
+152% +$180K
TCRT icon
217
Alaunos Therapeutics
TCRT
$4.19M
$298K 0.06%
341
-273
-44% -$239K
FGEN icon
218
FibroGen
FGEN
$49M
$297K 0.06%
263
-11
-4% -$12.4K
KALV icon
219
KalVista Pharmaceuticals
KALV
$781M
$297K 0.06%
+13,395
New +$297K
MGNX icon
220
MacroGenics
MGNX
$128M
$297K 0.06%
+17,519
New +$297K
ATNX
221
DELISTED
Athenex, Inc. Common Stock
ATNX
$297K 0.06%
749
-324
-30% -$128K
CCXI
222
DELISTED
ChemoCentryx, Inc.
CCXI
$297K 0.06%
31,973
+5,521
+21% +$51.3K
DNLI icon
223
Denali Therapeutics
DNLI
$2.27B
$296K 0.06%
14,246
+1,045
+8% +$21.7K
TVRD
224
Tvardi Therapeutics, Inc. Common Stock
TVRD
$289M
$296K 0.06%
+383
New +$296K
ADVM icon
225
Adverum Biotechnologies
ADVM
$72.2M
$293K 0.06%
+2,465
New +$293K
7 8
9
10 11